These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Functional outcome of botulinum toxin injection of gastrocnemius and adductors in spastic hemiplegic cerebral palsied children. Ibrahim AI; Hawamdeh ZM; Al-Qudah AA Eura Medicophys; 2007 Mar; 43(1):13-20. PubMed ID: 17021584 [TBL] [Abstract][Full Text] [Related]
3. [Botulinum toxin in the management of spastic hip adductors in non-ambulatory cerebral palsy children]. Deleplanque B; Lagueny A; Flurin V; Arnaud C; Pedespan JM; Fontan D; Pontallier JR Rev Chir Orthop Reparatrice Appar Mot; 2002 May; 88(3):279-85. PubMed ID: 12037484 [TBL] [Abstract][Full Text] [Related]
4. [Botulinum A in the treatment of equinus dynamic spasticity in children with cerebral palsy. Preliminary study]. Mousny M; Allington N Rev Chir Orthop Reparatrice Appar Mot; 1999 May; 85(2):156-63. PubMed ID: 10392416 [TBL] [Abstract][Full Text] [Related]
5. Long-term effects of botulinum toxin A in children with cerebral palsy. Tedroff K; Granath F; Forssberg H; Haglund-Akerlind Y Dev Med Child Neurol; 2009 Feb; 51(2):120-7. PubMed ID: 19191845 [TBL] [Abstract][Full Text] [Related]
6. Determinants of responsiveness to botulinum toxin, casting, and bracing in the treatment of spastic equinus in children with cerebral palsy. Yap R; Majnemer A; Benaroch T; Cantin MA Dev Med Child Neurol; 2010 Feb; 52(2):186-93. PubMed ID: 20412253 [TBL] [Abstract][Full Text] [Related]
7. Functional effects of botulinum toxin type A in the hip adductors and subsequent stretching in patients with hereditary spastic paraplegia. van Lith BJH; den Boer J; van de Warrenburg BPC; Weerdesteyn V; Geurts AC J Rehabil Med; 2019 Jun; 51(6):434-441. PubMed ID: 30968942 [TBL] [Abstract][Full Text] [Related]
8. Botulinum neurotoxin type A injections reduce spasticity in mild to moderate hereditary spastic paraplegia--report of 19 cases. Hecht MJ; Stolze H; Auf dem Brinke M; Giess R; Treig T; Winterholler M; Wissel J; Mov Disord; 2008 Jan; 23(2):228-33. PubMed ID: 17999430 [TBL] [Abstract][Full Text] [Related]
9. Botulinum toxin-a in children with congenital spastic hemiplegia does not improve upper extremity motor-related function over rehabilitation alone: a randomized controlled trial. Rameckers EA; Speth LA; Duysens J; Vles JS; Smits-Engelsman BC Neurorehabil Neural Repair; 2009; 23(3):218-25. PubMed ID: 19106252 [TBL] [Abstract][Full Text] [Related]
10. Functional effects of botulinum toxin type-A treatment and subsequent stretching of spastic calf muscles: a study in patients with hereditary spastic paraplegia. de Niet M; de Bot ST; van de Warrenburg BP; Weerdesteyn V; Geurts AC J Rehabil Med; 2015 Feb; 47(2):147-53. PubMed ID: 25325386 [TBL] [Abstract][Full Text] [Related]
11. Botulinum toxin a injections to the upper limbs in children with cerebral palsy: duration of effect. Fattal-Valevski A; Sagi L; Domenievitz D J Child Neurol; 2011 Feb; 26(2):166-70. PubMed ID: 20929909 [TBL] [Abstract][Full Text] [Related]
12. Botulinum toxin A for treatment of sialorrhea in children: an effective, minimally invasive approach. Khan WU; Campisi P; Nadarajah S; Shakur YA; Khan N; Semenuk D; McCann C; Roske L; McConney-Ellis S; Joseph M; Parra D; Amaral J; John P; Temple M; Connolly B Arch Otolaryngol Head Neck Surg; 2011 Apr; 137(4):339-44. PubMed ID: 21242533 [TBL] [Abstract][Full Text] [Related]
13. Botulinum toxin type A in children and adolescents with severe cerebral palsy: a retrospective chart review. Mesterman R; Gorter JW; Harvey A; Lockhart J; McEwen-Hill J; Margallo K; Goldie N J Child Neurol; 2014 Feb; 29(2):210-3. PubMed ID: 23965398 [TBL] [Abstract][Full Text] [Related]
14. Upper extremity function and occupational performance in children with spastic cerebral palsy following lower extremity botulinum toxin injections. Keren-Capelovitch T; Jarus T; Fattal-Valevski A J Child Neurol; 2010 Jun; 25(6):694-700. PubMed ID: 20508235 [TBL] [Abstract][Full Text] [Related]
15. Botulinum toxin (Dysport) treatment of the spastic gastrocnemius muscle in children with cerebral palsy: a randomized trial comparing two injection volumes. Hu GC; Chuang YC; Liu JP; Chien KL; Chen YM; Chen YF Clin Rehabil; 2009 Jan; 23(1):64-71. PubMed ID: 19114438 [TBL] [Abstract][Full Text] [Related]
16. [Botulinum toxin as a treatment for infantile cerebral palsy]. Pascual-Pascual SI; Sánchez de Muniain P; Roche MC; Pascual-Castroviejo I Rev Neurol; 1997 Sep; 25(145):1369-75. PubMed ID: 9377292 [TBL] [Abstract][Full Text] [Related]
17. Long-term effect of botulinum toxin (A) in the management of calf spasticity in children with diplegic cerebral palsy. Hawamdeh ZM; Ibrahim AI; Al-Qudah AA Eura Medicophys; 2007 Sep; 43(3):311-8. PubMed ID: 17268388 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of the effectiveness of botulinum toxin injections in the lower limb muscles of children with cerebral palsy. Preliminary prospective study of the advantages of ultrasound guidance. Py AG; Zein Addeen G; Perrier Y; Carlier RY; Picard A Ann Phys Rehabil Med; 2009 Apr; 52(3):215-23. PubMed ID: 19447084 [TBL] [Abstract][Full Text] [Related]
19. The role of botulinum toxin in the treatment of lower limb spasticity in children with cerebral palsy--a pilot study. Zelnik N; Giladi N; Goikhman I; Keren G; Moris R; Honigman S Isr J Med Sci; 1997 Feb; 33(2):129-33. PubMed ID: 9254875 [TBL] [Abstract][Full Text] [Related]
20. Botulinum toxin type A injections into the calf muscles for treatment of spastic equinus in cerebral palsy: a randomized trial comparing single and multiple injection sites. Sätilä H; Pietikäinen T; Iisalo T; Lehtonen-Räty P; Salo M; Haataja R; Koivikko M; Autti-Rämö I Am J Phys Med Rehabil; 2008 May; 87(5):386-94. PubMed ID: 18427220 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]